These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 26221333)
1. Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy. Zhang F; Ding R; Li P; Ma C; Song D; Wang X; Ma T; Bi L Int J Clin Exp Med; 2015; 8(5):7809-15. PubMed ID: 26221333 [TBL] [Abstract][Full Text] [Related]
2. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis]. Jin YJ; Sun L; Yang L; Xing R; Liu XY Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495 [TBL] [Abstract][Full Text] [Related]
3. Potential significance of changes in serum levels of IL-17, TNF-α and DKK-1 in the progression of the rheumatoid arthritis. Wang Q; Liu Y; Wu J; Chen S; Hu T; Liu Y; Li X; Li X; Wu Y; Yu J; Zeng T; Luo Y; Hu X; Tan LM Autoimmunity; 2023 Dec; 56(1):2276068. PubMed ID: 37909152 [TBL] [Abstract][Full Text] [Related]
4. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525 [TBL] [Abstract][Full Text] [Related]
5. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185 [TBL] [Abstract][Full Text] [Related]
7. [Regulatory effect of moxibustion on LTB4/MMP-9 in serum of patients with rheumatoid arthritis]. Tang J; Wu P; Yu ZY; Wang X; Tao SY; Jiang NN; Chen GH; Shuai RX Zhen Ci Yan Jiu; 2023 May; 48(5):488-93. PubMed ID: 37247863 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-3 levels in relation to disease activity and radiological progression in rheumatoid arthritis. Tuncer T; Kaya A; Gulkesen A; Kal GA; Kaman D; Akgol G Adv Clin Exp Med; 2019 May; 28(5):665-670. PubMed ID: 30740946 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis. Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934 [TBL] [Abstract][Full Text] [Related]
10. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction. Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531 [TBL] [Abstract][Full Text] [Related]
11. Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab. Kawashiri SY; Kawakami A; Ueki Y; Imazato T; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Origuchi T; Ida H; Eguchi K Joint Bone Spine; 2010 Oct; 77(5):418-20. PubMed ID: 20864374 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Xiangyang Z; Lutian Y; Lin Z; Liping X; Hui S; Jing L Cytokine; 2012 Apr; 58(1):6-9. PubMed ID: 22239947 [TBL] [Abstract][Full Text] [Related]
15. [Clinical value of serum matrix metalloproteinase-3 in evaluating joint destruction and therapeutic effect in rheumatoid arthritis patients]. Li L; Cai B; Liao J; Yang B; Huang Z; Wang L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):966-9. PubMed ID: 24011160 [TBL] [Abstract][Full Text] [Related]
16. Elevated Serum Levels of Interleukin-29 Are Associated with Disease Activity in Rheumatoid Arthritis Patients with Anti-Cyclic Citrullinated Peptide Antibodies. Chang QJ; Lv C; Zhao F; Xu TS; Li P Tohoku J Exp Med; 2017 Feb; 241(2):89-95. PubMed ID: 28154345 [TBL] [Abstract][Full Text] [Related]
17. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis. Shimamoto K; Ito T; Ozaki Y; Amuro H; Tanaka A; Nishizawa T; Son Y; Inaba M; Nomura S J Rheumatol; 2013 Jul; 40(7):1074-81. PubMed ID: 23637318 [TBL] [Abstract][Full Text] [Related]
18. APRIL Level as a Marker of Disease Activity in Treated Rheumatoid Arthritis Patients: Association with Disease Activity and Anti-CCP Antibody. Boghdadi G; El-Sokkary RH; Elewa EA; Abbas SF Egypt J Immunol; 2015 Jun; 22(2):31-39. PubMed ID: 28502142 [TBL] [Abstract][Full Text] [Related]
19. Relation between bone mineral density and IL-17 serum levels in Serbian patients with early Rheumatoid arthritis. Pavlovic V; Dimic A; Milenkovic S; Krtinic D; Aleksic I Open Med (Wars); 2015; 10(1):106-112. PubMed ID: 28352685 [TBL] [Abstract][Full Text] [Related]
20. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis]. Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]